Autologous hematopoietic stem cells for refractory Crohn’s disease

References

• Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002 Jan;15(1):79–94.
   PubMed Web of Science ®Google Scholar
• Hanauer SB, Sandborn W, Col PPCA. Management of Crohn’s disease in adults. Am J Gastroenterol. 2001 Mar;96(3):635–643.
   PubMed Web of Science ®Google Scholar
• Silva FA, Rodrigues BL, Ayrizono ML, et al. The immunological basis of inflammatory bowel disease. Gastroenterol Res Pract. 2016;2016:2097274.
   PubMed Web of Science ®Google Scholar
• Danese S, Semeraro S, Papa A, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005 Dec 14;11(46):7227–7236.
   PubMed Web of Science ®Google Scholar
• Sandborn WJ, Present T. Future of inflammatory bowel disease treatment. Gastroenterol Hepatol (N Y). 2016 Jul;12(7):438–441.
   PubMedGoogle Scholar
• Bethesda M NIH stem cell information. 2016 [cited 2016 Sep 29]; Available from: https://stemcells.nih.gov/info/basics/5.htm
   Google Scholar
• Panes J, Ordas I, Ricart E. Stem cell treatment for Crohn’s disease. Expert Rev Clin Immunol. 2010 Jul;6(4):597–605.
   PubMed Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature. 2001 Nov 01;414(6859):105–111.
   PubMed Web of Science ®Google Scholar
• Kavanagh DP, Kalia N. Hematopoietic stem cell homing to injured tissues. Stem Cell Rev. 2011 Sep;7(3):672–682.
   PubMed Web of Science ®Google Scholar
• Martinez-montiel mdel P, Gomez-Gomez GJ, Flores AI. Therapy with stem cells in inflammatory bowel disease. World J Gastroenterol. 2014 Feb 07;20(5):1211–1227.
   PubMed Web of Science ®Google Scholar
• Kapoor S, Wilson AG, Sharrack B, et al. Haemopoietic stem cell transplantation–an evolving treatment for severe autoimmune and inflammatory diseases in rheumatology, neurology and gastroenterology. Hematology. 2007 Jun;12(3):179–191.
   PubMed Web of Science ®Google Scholar
• Burt RK, Marmont A, Oyama Y, et al. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum. 2006 Dec;54(12):3750–3760.
   PubMed Web of Science ®Google Scholar
• Farge D, Labopin M, Tyndall A, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years’ experience from the European group for blood and marrow transplantation working party on autoimmune diseases. Haematologica. 2010 Feb;95(2):284–292.
   PubMed Web of Science ®Google Scholar
• Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 2005 May;35(9):869–879.
   PubMed Web of Science ®Google Scholar
• Sonwalkar SA, James RM, Ahmad T, et al. Fulminant Crohn’s colitis after allogeneic stem cell transplantation. Gut. 2003 Oct;52(10):1518–1521.
   PubMed Web of Science ®Google Scholar
• Jones B, Kramer SS, Saral R, et al. Gastrointestinal inflammation after bone marrow transplantation: graft-versus-host disease or opportunistic infection? AJR Am J Roentgenol. 1988 Feb;150(2):277–281.
   PubMed Web of Science ®Google Scholar
• Li HW, Sykes M. Emerging concepts in haematopoietic cell transplantation. Nat Reviews Immunol. 2012 May 25;12(6):403–416.
   PubMed Web of Science ®Google Scholar
• Burt RK, Craig RM, Milanetti F, et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in patients with severe anti-TNF refractory Crohn disease: long-term follow-up. Blood. 2010 Dec 23;116(26):6123–6132.
   PubMed Web of Science ®Google Scholar
• Alexander T, Thiel A, Rosen O, et al. Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system. Blood. 2009 Jan 01;113(1):214–223.
   PubMed Web of Science ®Google Scholar
• Clerici M, Cassinotti A, Onida F, et al. Immunomodulatory effects of unselected haematopoietic stem cells autotransplantation in refractory Crohn’s disease. Dig Liver Dis. 2011 Dec;43(12):946–952.
   PubMedGoogle Scholar
• Darlington PJ, Touil T, Doucet JS, et al. Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation. Ann Neurol. 2013 Mar;73(3):341–354.
   PubMed Web of Science ®Google Scholar
• Abrahamsson SV, Angelini DF, Dubinsky AN, et al. Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis. Brain. 2013 Sep;136(Pt 9):2888–2903.
   PubMed Web of Science ®Google Scholar
• Burt RK, Loh Y, Cohen B, et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol. 2009 Mar;8(3):244–253.
   PubMed Web of Science ®Google Scholar
• Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med. 2005 Mar 07;201(5):805–816.
   PubMed Web of Science ®Google Scholar
• Szczechowski L, Smilowski M, Helbig G, et al. Autologous hematopoietic stem cell transplantation (AHSCT) for aggressive multiple sclerosis - whom, when and how. Int J Neurosci. 2016 Oct;126(10):867–871.
   PubMed Web of Science ®Google Scholar
• Okamoto R, Watanabe M. Molecular and clinical basis for the regeneration of human gastrointestinal epithelia. J Gastroenterol. 2004 Jan;39(1):1–6.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Okamoto R, Yajima T, et al. Increase of bone marrow-derived secretory lineage epithelial cells during regeneration in the human intestine. Gastroenterology. 2005 Jun;128(7):1851–1867.
   PubMed Web of Science ®Google Scholar
• Brittan M, Chance V, Elia G, et al. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology. 2005 Jun;128(7):1984–1995.
   PubMed Web of Science ®Google Scholar
• Hayashi Y, Tsuji S, Tsujii M, et al. The transdifferentiation of bone-marrow-derived cells in colonic mucosal regeneration after dextran-sulfate-sodium-induced colitis in mice. Pharmacology. 2007;80(4):193–199.
   PubMed Web of Science ®Google Scholar
• Andoh A, Bamba S, Fujiyama Y, et al. Colonic subepithelial myofibroblasts in mucosal inflammation and repair: contribution of bone marrow-derived stem cells to the gut regenerative response. J Gastroenterol. 2005 Dec;40(12):1089–1099.
   PubMed Web of Science ®Google Scholar
• Snowden JA, Saccardi R, Allez M, et al. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European group for blood and marrow transplantation. Bone Marrow Transplant. 2012 Jun;47(6):770–790.
   PubMed Web of Science ®Google Scholar
• Duran NE, Hommes DW. Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls. Therap Adv Gastroenterol. 2016 Jul;9(4):533–547.
   PubMed Web of Science ®Google Scholar
• Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol. 2005 Jul;141(1):1–9.
   PubMed Web of Science ®Google Scholar
• Cassinotti A, Annaloro C, Ardizzone S, et al. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn’s disease. Gut. 2008 Feb;57(2):211–217.
   PubMed Web of Science ®Google Scholar
• Tyndall A, Gratwohl A. Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 1997 Apr;19(7):643–645.
   PubMed Web of Science ®Google Scholar
• Jauregui-Amezaga A, Rovira M, Marin P, et al. Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn’s disease. Gut. 2016 Sep;65(9):1456–1462.
   PubMed Web of Science ®Google Scholar
• Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia. 2007 Jul;21(7):1387–1394.
   PubMed Web of Science ®Google Scholar
• Oyama Y, Craig RM, Traynor AE, et al. Autologous hematopoietic stem cell transplantation in patients with refractory Crohn’s disease. Gastroenterology. 2005 Mar;128(3):552–563.
   PubMed Web of Science ®Google Scholar
• Scime R, Cavallaro AM, Tringali S, et al. Complete clinical remission after high-dose immune suppression and autologous hematopoietic stem cell transplantation in severe Crohn’s disease refractory to immunosuppressive and immunomodulator therapy. Inflamm Bowel Dis. 2004 Nov;10(6):892–894.
   PubMed Web of Science ®Google Scholar
• Tyndall A, Black C, Finke J, et al. Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet. 1997 Jan 25;349(9047):254.
   PubMed Web of Science ®Google Scholar
• Marmont A, Tyndall A, Gratwohl A, et al. Hematopoietic precursor-cell transplants for autoimmune-diseases. Lancet. 1995 Apr 15;345(8955):978.
   PubMed Web of Science ®Google Scholar
• Burt RK, Traynor A, Statkute L, et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. Jama. 2006 Feb 01;295(5):527–535.
   PubMed Web of Science ®Google Scholar
• Kashyap A, Forman SJ. Autologous bone marrow transplantation for non-Hodgkin’s lymphoma resulting in long-term remission of coincidental Crohn’s disease. Br J Haematol. 1998 Dec;103(3):651–652.
   PubMed Web of Science ®Google Scholar
• Musso M, Porretto F, Crescimanno A, et al. Crohn’s disease complicated by relapsed extranodal Hodgkin’s lymphoma: prolonged complete remission after unmanipulated PBPC autotransplant. Bone Marrow Transplant. 2000 Oct;26(8):921–923.
   PubMed Web of Science ®Google Scholar
• Soderholm JD, Malm C, Juliusson G, et al. Long-term endoscopic remission of crohn disease after autologous stem cell transplantation for acute myeloid leukaemia. Scand J Gastroenterol. 2002 May;37(5):613–616.
   PubMed Web of Science ®Google Scholar
• Castro J, Bentch HL, Smith L, et al. Prolonged clinical remission in patients (pts) with inflammatory bowel disease (IBD) after high dose chemotherapy (HDC) and autologous blood stem cell transplantation (ABSCT). Blood. 1996 Nov 15;88(10):519.
   Web of Science ®Google Scholar
• Drakos PE, Nagler A, Or R. Case of Crohn’s disease in bone marrow transplantation. Am J Hematol. 1993 Jun;43(2):157–158.
   PubMed Web of Science ®Google Scholar
• Anumakonda V, Hayee B, Chung-Faye G. Remission and relapse of Crohn’s disease following autologous haematopoietic stem cell transplantation for non-Hodgkin’s lymphoma. Gut. 2007 Sep;56(9):1325.
   PubMed Web of Science ®Google Scholar
• Leung Y, Geddes M, Storek J, et al. Hematopoietic cell transplantation for Crohn’s disease; is it time? World J Gastroenterol. 2006 Nov 07;12(41):6665–6673.
   PubMed Web of Science ®Google Scholar
• Hasselblatt P, Drognitz K, Potthoff K, et al. Remission of refractory Crohn’s disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther. 2012 Oct;36(8):725–735.
   PubMed Web of Science ®Google Scholar
• Burt RK, Traynor A, Oyama Y, et al. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn disease. Blood. 2003 Mar 01;101(5):2064–2066.
   PubMed Web of Science ®Google Scholar
• Craig RM, Traynor A, Oyama Y, et al. Hematopoietic stem cell transplantation for severe Crohn’s disease. Bone Marrow Transplant. 2003 Aug;32(Suppl 1):S57–9.
   PubMed Web of Science ®Google Scholar
• Hommes DW, Duijvestein M, Zelinkova Z, et al. Long-term follow-up of autologous hematopoietic stem cell transplantation for severe refractory Crohn’s disease. J Crohn’s Colitis. 2011 Dec;5(6):543–549.
   Google Scholar
• Kreisel W, Potthoff K, Bertz H, et al. Complete remission of Crohn’s disease after high-dose cyclophosphamide and autologous stem cell transplantation. Bone Marrow Transplant. 2003 Aug;32(3):337–340.
   PubMed Web of Science ®Google Scholar
• Kountouras J, Sakellari I, Tsarouchas G, et al. Autologous haematopoietic stem cell transplantation in a patient with refractory Crohn’s disease. J Crohns Colitis. 2011 Jun;5(3):275–276.
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Allez M, Clark MM, et al. Autologous hematopoetic stem cell transplantation for refractory Crohn disease: a randomized clinical trial. Jama. 2015 Dec 15;314(23):2524–2534.
   PubMed Web of Science ®Google Scholar
• Hommes DW, Lacey PN. Stem cells: HSCT for Crohn’s disease: work in progress or a bridge too far? Nat Rev Gastroenterol Hepatol. 2016 Mar;13(3):128–130.
   PubMed Web of Science ®Google Scholar
• Burt RK, Ruiz MA, Kaiser RL Jr. Stem cell transplantation for refractory Crohn disease. Jama. 2016 Jun 21; 315(23):2620.
   PubMed Web of Science ®Google Scholar
• Hawkey CJ, Hommes DW. Is stem cell therapy ready for prime time in treatment of inflammatory bowel diseases. Gastroenterology. 2016 Nov 11;152:389–397.
   PubMed Web of Science ®Google Scholar